NSE
Bajaj Healthcare LimitedBAJAJHCARE
Bajaj Healthcare Limited is an Indian healthcare company focused on providing medical devices, consumables, and services.
| Key products | Medical devices, diagnostic products, imaging solutions |
|---|---|
| Geography | India (domestic market) |
| Competitors | Mindtree Healthcare, Apollo Hospitals Enterprises |
AI-generated overview — verify before relying on it.
Net institutional flow
No institutional deals
Institutional buyers
0 in / 0 out
High-impact filings
0 · tilt Neutral
Next corporate action
Dividend - Re 1 Per Share
ex 2025-09-19
| # | Company | Inst. flow ₹Cr | Deals | Hi-impact | Filing mom. | Buzz | News |
|---|---|---|---|---|---|---|---|
| 1 | ATALREAL | +₹15.1 Cr | 267 | — | — | — | — |
| 2 | MOBIKWIK | +₹5.2 Cr | 355 | — | — | — | — |
| 3 | MTNL | +₹0.1 Cr | 26 | — | — | — | — |
| 4 | BAJAJHCAREThis | +₹0 Cr | 3 | — | — | — | — |
| 5 | GATECH | −₹0.3 Cr | 77 | — | — | — | — |
| 6 | IRMENERGY | −₹2.2 Cr | 356 | — | — | — | — |
| 7 | QUADFUTURE | −₹7.9 Cr | 177 | — | — | — | — |
Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.
SWOT
Strengths
- • Strong brand presence in India
- • Diversified product portfolio with a focus on innovation
- • Established distribution network across the country
- • Consistent revenue growth over the years
Weaknesses
- • Dependence on a few key products
- • High research and development expenses as a percentage of sales
- • Competition from global players in emerging markets
- • Regulatory challenges in the healthcare sector
Opportunities
- • Growing demand for medical devices in emerging economies
- • Increasing adoption of digital health technologies
- • Expansion into new product categories such as telemedicine services
- • Partnerships with pharmaceutical companies to offer bundled solutions
Threats
- • Global economic downturn affecting consumer spending on healthcare
- • Compliance risks due to changing regulations and standards
- • Intense competition from local players in the Indian market
- • Supply chain disruptions due to geopolitical tensions
AI-generated from our data — verify before relying on it.
- 2026-03-18BulkSELL · ₹6.7 CrRIKHAV SECURITIES LIMITED
- 2026-03-18NetDay net −₹6.7 Cr
- 2025-09-24BulkBUY · ₹10.5 CrGRAVITON RESEARCH CAPITAL LLP
- 2025-09-24BulkSELL · ₹10.5 CrGRAVITON RESEARCH CAPITAL LLP
- 2025-09-24NetDay net −₹0 Cr
- 2025-09-19ActionDividend - Re 1 Per ShareDividend
Merged from deals, filings, corporate actions and news — newest first. Compact rolls each day up to net flow + counts. Scope with the range above.
Filings that matter
No scored filings for BAJAJHCARE yet.
3 deals · 2025-09-24 → 2026-03-18
| Date | Counterparty | Type | Side | Value |
|---|---|---|---|---|
| 2026-03-18 | RIKHAV SECURITIES LIMITED | Prop / churn | SELL | ₹6.7 Cr |
| 2025-09-24 | GRAVITON RESEARCH CAPITAL LLP | Prop / churn | BUY | ₹10.5 Cr |
| 2025-09-24 | GRAVITON RESEARCH CAPITAL LLP | Prop / churn | SELL | ₹10.5 Cr |
3 deals in the selected window — corporate actions are scoped to the same period. ~2 years of history available.
News & chatter on BAJAJHCARE
RSS News
0No recent news.
Google News RSS — links open the source.
Investdesk
0No articles yet.
Our coverage.
No Reddit chatter.
r/ posts mentioning the company.
Twitter / X
0No posts.
Posts mentioning the company.